Table 2 Minimum inhibitory concentration tests were conducted to identify the sensitivities of 20 clinical isolates of Pseudomonas aeruginosa to the antibiotics: ceftazidime, ciprofloxacin, imipenem, and tobramycin
Tobramycin | Ceftazidime | Ciprofloxacin | Imipenem | |||||
|---|---|---|---|---|---|---|---|---|
MIC | S/R | MIC | S/R | MIC | S/R | MIC | S/R | |
PAO1 | 0.33 | S | 3.33 | S | 0.67 | R | 2.67 | S |
PA05 | 0.25 | S | 1.00 | S | 0.42 | S | 1.33 | S |
PA08 | 0.83 | S | 64.00 | R | 0.25 | S | 0.83 | S |
PA10 | 0.42 | S | 2.33 | S | 0.33 | S | 0.67 | S |
PA15 | 2.67 | R | 0.83 | S | 0.50 | S | 1.00 | S |
PA20 | 0.42 | S | 0.67 | S | 0.58 | R | 1.17 | S |
PA21 | 0.58 | S | 42.67 | R | 0.25 | S | 21.33 | R |
PA26 | 0.67 | S | 256.00 | R | 0.67 | R | 26.67 | R |
PA30 | 0.25 | S | 7.50 | S | 0.67 | R | 9.33 | R |
PA31 | 2.33 | R | 60.00 | R | 0.33 | S | 7.50 | R |
PA37 | 0.50 | S | 85.33 | R | 1.00 | R | 3.75 | S |
PA39 | 0.58 | S | 4.00 | S | 0.58 | R | 4.67 | R |
PA44 | 85.33 | R | 22.67 | R | 0.83 | R | 3.33 | S |
PA49 | 42.67 | R | 64.00 | R | 0.67 | R | 18.67 | R |
PA55 | 213.33 | R | 27.00 | R | 0.83 | R | 1.33 | S |
PA56 | 64.00 | R | 74.00 | R | 1.17 | R | 6.67 | R |
PA57 | 26.67 | R | 53.33 | R | 0.58 | R | 5.33 | R |
PA58 | 32.00 | R | 64.00 | R | 0.58 | R | 10.67 | R |
PA66 | 64.00 | R | 64.00 | R | 1.12 | R | 10.67 | R |
PA68 | 26.67 | R | 64.00 | R | 0.42 | S | 1.67 | S |
